Ethics & Informed Consent: Qualitative Interview & Focus Group Research (Austria)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Qualitative Interview & Focus Group Research being conducted in Austria, study designs must align with the primary regulatory legislation: Medicines Act (Arzneimittelgesetz - AMG). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Ethikkommission (Ethics Commission). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Qualitative Interview & Focus Group Research, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: Minimal Risk

Dialogue is the core data of qualitative designs. Consent sheets must detail how identifiers will be scrubbed from transcripts, and remind focus group participants of mutual privacy limits.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: COREQ checklist.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Austrian Data Protection Act (Datenschutzgesetz - DSG).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Ethikkommission (Ethics Commission) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Applying the Declaration of Helsinki ethical principles to this qualitative Qualitative Interview & Focus Group Research means respecting participant self-determination. Any study requiring any deception in psychological research must be pre-approved by the Ethikkommission (Ethics Commission) with a thorough debriefing plan. The consenting workflow must actively support the ethical principles of informed consent, ensuring full transparency. Although qualitative designs do not require a clinical trial registration, securing a signed clinical trial agreement contract is often required for hospital sites. Submitting a robust data privacy plan is the final step to secure complete research ethics approval from the Ethikkommission (Ethics Commission). All records and signed consent sheets must reside on secure local servers in Austria to protect patient privacy and comply with national guidelines.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions